Deals

AstraZeneca shares rise as fresh reports deny mega-merger talks with US rival

1 source ·1 article ·Aug 5, 21:01 UTC Astrazeneca

Astra's stock climbed 2.5% or 296p to 12,036p after Reuters quoted a senior source at the business quashing rumours of any potential tie-up.

Covered by 1 outlet

All coverage · 1 article

Astra's stock climbed 2.5% or 296p to 12,036p after Reuters quoted a senior source at the business quashing rumours of any potential tie-up.